US FDA sends warning letter to Philips over three device production facilities
28/10/2025 14:55
Oct 28 (Reuters) - The U.S. Food and Drug Administration has issued a warning letter to Philips PHG.AS after inspections at three of its medical device facilities found they had failed to meet required manufacturing standards, according to an update on the agency's website on Tuesday. (Reporting by Sruthi Narasimha Chari and Kamal Choudhury in Bengaluru) ((SruthiNarasimha.Chari@thomsonreuters.com))
Recent news on Koninklijke Philips
See all newsBrief: Philips Launches Hypervue Integrated System In The U.S., Bringing Advanced Coronary Imaging And Physiology Into The Cathlab
Citi lifts ResMed's ASX-listed stock's target price after FX, valuation updates
Philips wins Dutch court battle with shareholders over recall
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
Brief: SA's Competition Commission Refers GE, Siemens, Philips Units To Tribunal For Alleged Anticompetitive Conduct